-
-
-
-
-
-
-
Valeant Pharma (VRX) to Acquire Obagi Medical (OMPI) for $19.75/Share
-
-
-
-
-
-
-
Cantor Fitzgerald Downgrades Obagi Medical Products (OMPI) to Hold; Slowing Growth and Speculation
-
-
-
-
-
-
-
Obagi Medical Products, Inc. (OMPI) Tops Q4 EPS by 5c
-
-
-
-
-
-
975,610 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All